UltraSight AI Guidance
Overview
UltraSight AI Guidance is an innovative, AI-driven software designed to revolutionize cardiac sonography by making high-quality cardiac ultrasound imaging accessible to a broader range of healthcare professionals. The mobile AI-based application pairs with compatible general-purpose diagnostic ultrasound systems, including handheld, laptop, and cart-based devices. It provides real-time guidance and quality assessment, assisting medical professionals, even those without prior sonography experience, in acquiring diagnostic-quality 2D transthoracic echocardiography (2D-TTE) images.
The software analyzes the ultrasound stream and offers dynamic, real-time instructions on how to maneuver the ultrasound probe in three dimensions (X, Y, and Z axes) to achieve optimal views. A continuous quality bar score and graphical probe manipulation cues help users maintain proper transducer positioning and ensure diagnostic image quality. UltraSight AI Guidance supports the acquisition of 10 standard cardiac views, enabling faster diagnosis, earlier treatment, and increased patient access to critical cardiac care in various settings, including clinics, community hospitals, emergency departments, and remote areas.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Real-time AI guidance for ultrasound probe positioning and orientation
- Image quality assessment and feedback (quality bar score)
- Guidance for 10 standard cardiac views (e.g., PLAX, AP4, SubC4)
- 3D guidance user interface with magnitude of movement instructions
- Continuous real-time guidance and movement tracking
- Compatibility with various ultrasound systems (handheld, laptop, cart-based)
- Mobile AI-based application for tablets
- Enables non-sonographers to acquire diagnostic-quality images
- Supports faster diagnosis and earlier treatment
- Reduces repeat imaging and increases operational efficiency
Use Cases
- Point-of-Care Ultrasound (PoCUS) in emergency departments
- Out-of-hospital care and remote/rural areas
- Early detection of Stage B heart failure
- Screening for structural heart disease
- Maternal health cardiac assessments
- Management of patients with microaxial flow pumps (PVAD IQ)
What Physicians Need to Know
UltraSight AI Guidance empowers healthcare professionals, including those without prior sonography experience, to acquire diagnostic-quality cardiac ultrasound images, thereby expanding access to critical cardiac imaging. It can accelerate skill acquisition for residents and reduce variability in focused cardiac ultrasound (FoCUS) exams. Physicians should view this as an assistive tool to enhance diagnostic efficiency and patient access, particularly for screening, surveillance, and in critical care settings, while maintaining qualified physician oversight for final interpretation and reporting. The technology has demonstrated high accuracy in detecting conditions like reduced LVEF and aortic stenosis when used by novice scanners.
UltraSight AI Guidance is an accessory to compatible general-purpose diagnostic ultrasound systems. It has received FDA clearance for expanded compatibility with a wider variety of ultrasound systems, including handheld, laptop, and cart-based devices, allowing deployment across existing ultrasound fleets without requiring new hardware. The software is compatible with the Philips Lumify Ultrasound System and is integrating with Butterfly Network's imaging platform for use with their single-probe, whole-body handheld ultrasound system.
Details
| Category | Cardiology AI |
| Pricing | Contact for pricing — Contact for pricing; custom enterprise pricing available. |
| Deployment | Mobile AI software application, pairs with compatible general-purpose diagnostic ultrasound devices. |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated UltraSight AI Guidance received FDA 510(k) clearance on July 24, 2023 (K223347) for assisting medical professionals (not expert sonographers) in acquiring 10 standard 2D transthoracic echocardiography (2D-TTE) views for adult patients. An expanded clearance was granted on January 6, 2026, to support compatibility with a wider variety of ultrasound systems (handheld, laptop, cart-based). |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology, Critical Care, Emergency Medicine |
What the Web Says
UltraSight AI Guidance is an AI-powered software designed to assist medical professionals, including those without prior sonography experience, in acquiring high-quality cardiac ultrasound images. The system provides real-time guidance and quality assessment, aiming to expand access to cardiac imaging and facilitate earlier diagnosis and treatment of heart conditions. Studies have shown that novice users, after minimal training, can obtain diagnostic-quality images comparable to those acquired by expert sonographers.
Overall: PositiveStrengths
- Enables novice users to acquire diagnostic-quality cardiac ultrasound images with minimal training.
- Expands access to cardiac imaging in various care settings, including remote and rural areas.
- Reduces the learning curve and training time for performing echocardiograms.
- Provides real-time AI guidance and feedback for probe manipulation and image quality assessment.
- Supports faster diagnosis and more timely clinical decisions.
- Can be deployed across existing ultrasound fleets, including handheld, laptop, and cart-based systems.
Limitations
- No specific cons were found in the provided search results.
- Potential resistance from some radiologists to widespread adoption of AI in ultrasound.
Based on reviews from: UltraSight, StartupHub.ai, BioWorld, EIN Presswire, AdvaMedu00ae, PMC, The National Law Review, AuntMinnie, Reddit, accessdata.fda.gov, ProQuest, Definitive Healthcare
Last updated: 2026-07-19
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate UltraSight AI Guidance
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for UltraSight AI Guidance.
2026 UltraSight Journal Club with Dr. Andre Kumar
